Heparin Market will rise to US$ 3.5 Billion by 2024

Text-only Preview

Heparin Market - Europe Industry Analysis, Size, Share,
Growth, Trends, and Forecast 2016 2024
Europe is among the major regions contributing to the global heparin market
owing to its developed economy and high prevalence of coagulation disorders.
According to the Ageing Report published by the European Commission in
2015, the percentage of population aged above 65 years is expected to increase
from 21.0% in 2013 to 32.0% in 2060. Aging is directly proportional to the
rising incidence of venous thromboembolism (VTE) diseases such as deep vein
thrombosis (DVT) and pulmonary embolism (PE). Hence, the demand for
heparin in Europe is expected to increase in the next few years. The heparin
market in Europe was valued at US$2.2 bn in 2015 and is projected to expand
at a CAGR of 5.2% from 2016 to 2024 to reach US$3.5 bn in 2024.
Based on end user, the heparin market in Europe has been categorized into
hospitals, blood and stem cell banks, and others. Hospitals and clinics widely
use heparin as a blood thinner in the treatment of various diseases related to
cardiovascular, cancer, and orthopedic. Heparin such as Calcilean, Calciparine,
Hepalean, Heparin Leo, and Hepalean-lok are prominently used in hospitals
for surgical purposes. The hospitals segment accounted for a major share of
the heparin market in Europe as most surgical procedures are often performed
in hospitals.
The blood and stem cell banks segment also held a significant share of the
market in 2015. Blood and stem cell banks use heparin to collect cord blood
and stem cells as heparin promotes the growth of human embryonic stem cells
in a defined serum-free medium.
Browse Full Research Report on Antiviral Drugs Market:
http://www.transparencymarketresearch.com/europe-heparin-market.html
The heparin market in Europe has been segmented on the basis of geography
into the following major markets: Germany, France, the U.K., Italy, Spain,
Poland, Switzerland, Austria, Hungary, Belgium, Portugal, the Czech
Republic, Greece, Slovakia, and Rest of Europe.
Germany accounted for the leading share in the heparin market in Europe in
2015 and is expected to continue its dominance till 2024. Key attributes to the
market growth in Germany encompass burgeoning incidence o f VTE among
patients, resulting in the increased demand for heparin. Moreover, stringent
regulations pertaining to Chinese active pharmaceutical ingredients (APIs) due
to adulteration issues have attracted new players to the heparin processing and
manufacturing business in Europe. Europe has been known to adhere to strict
regulations pertaining to the import of heparin. For instance, in 2013,
Germany-based meat company, Tönnies GmbH & Co, acquired Pharma
Action, a heparin API manufacturer, and proposed to manufacture 30 metric
tons of heparin API. Such developments are expected to augment the heparin
market’s growth in Germany.
France, Belgium, and Portugal are anticipated to register the highest growth in
the coming years. France also held the second position in the heparin market
in Europe in 2015. Heparin consumption during and after surgical procedures
such as knee replacement, hip surgery, appendectomy, and breast surgery is
higher in France as compared to Italy, Spain, and the U.K. The increased risk
of thrombosis among the geriatric population is also expected to drive the
market for heparin in France.
Major players in the Europe heparin market include Sanofi SA, Pfizer, Inc.,
Leo Pharma, Teva Pharmaceutical Industries Ltd, and Dr. Reddy’s
Laboratories.
Browse Full Press Release on Antiviral Drugs Market:
About Us
Transparency Market Research (TMR) is a global market intelligence
company providing business information reports and services. The company’s
exclusive blend of quantitative forecasting and trend analysis provides
forward-looking insight for thousands of decision makers. TMR’s experienced
team of analysts, researchers, and consultants use proprietary data sources and
various tools and techniques to gather and analyze information.
TMR’s data repository is continuously updated and revised by a team of
research experts so that it always reflects the latest trends and information.
With extensive research and analysis capabilities, Transparency Market
Research employs rigorous primary and secondary research techniques to
develop distinctive data sets and research material for business reports.
Contact Us
Transparency Market Research
State Tower,
90 State Street, Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com
Press Release